术前骨骼肌密度低可预测老年卵巢癌患者术后不良结局
这项多中心回顾性队列研究纳入213例≥70岁接受初次手术的晚期卵巢癌患者,用L3层面CT评估骨骼肌质量与密度。结果显示术前低骨骼肌密度与术后30天内并发症、严重并发症、感染并发症及出院至护理机构相关,且在多变量模型中对术后并发症有独立预测价值。
要点
- 术前低骨骼肌密度与术后30天内并发症风险升高相关(OR 2.83)。
- 低骨骼肌密度还与非计划出院至护理机构及严重并发症相关。
- 低骨骼肌质量仅与感染并发症相关,预测价值不如密度。
核心结论
- 术前低骨骼肌密度作为肌肉质量的替代指标,与老年晚期卵巢癌患者术后不良结局相关。
- 该发现有助于术后风险评估和临床决策。
研究设计与样本
- 多中心回顾性队列研究,纳入213例≥70岁接受初次手术的晚期卵巢癌患者。
- 在L3层面轴位CT评估骨骼肌质量和密度。
- 低骨骼肌质量定义为骨骼肌指数<38.50 cm2/m2,低骨骼肌密度定义为低于均值一个标准差(肌肉衰减<22.55 HU)。
主要发现
- 术前低骨骼肌密度与术后30天内并发症相关(OR 2.83;95%CI 1.41-5.67)。
- 术前低骨骼肌密度与严重并发症相关(OR 3.01;95%CI 1.09-8.33)。
- 术前低骨骼肌密度与感染并发症相关(OR 2.79;95%CI 1.30-5.99)。
- 术前低骨骼肌密度与出院至护理机构相关(OR 3.04;95%CI 1.16-7.93)。
- 术前低骨骼肌质量仅与感染并发症相关(OR 2.32;95%CI 1.09-4.92)。
关键数值与推荐
- 低骨骼肌质量阈值:骨骼肌指数<38.50 cm2/m2。
- 低骨骼肌密度阈值:肌肉衰减<22.55 HU(低于均值一个标准差)。
- 多变量模型中,低骨骼肌密度对术后并发症的预测值(OR 2.57;95%CI 1.21-5.45)高于现有最强预测因子功能受损(KATZ-ADL ≥ 2)。
临床怎么用
- 对老年晚期卵巢癌患者,可考虑术前CT评估L3层面骨骼肌密度以辅助术后风险分层。
- 低骨骼肌密度患者可能需要加强术后并发症监测和出院规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the predictive value of lumbar skeletal muscle mass and density for postoperative outcomes in older women with advanced stage ovarian cancer. METHODS: A multicenter, retrospective cohort study was performed in women ≥ 70 years old receiving surgery for primary, advanced stage ovarian cancer. Skeletal muscle mass and density were assessed in axial CT slices on level L3. Low skeletal muscle mass was defined as skeletal muscle index < 38.50 cm2/m2. Low skeletal muscle density was defined as one standard deviation below the mean (muscle attenuation < 22.55 Hounsfield Units). The primary outcome was any postoperative complication ≤ 30 days after surgery. Secondary outcomes included severe complications, infections, delirium, prolonged hospital stay, discharge destination, discontinuation of adjuvant chemotherapy and mortality. RESULTS: In analysis of 213 patients, preoperative low skeletal muscle density was associated with postoperative complications ≤ 30 days after surgery (Odds Ratio (OR) 2.83; 95% Confidence Interval (CI) 1.41-5.67), severe complications (OR 3.01; 95%CI 1.09-8.33), infectious complications (OR 2.79; 95%CI 1.30-5.99) and discharge to a care facility (OR 3.04; 95%CI 1.16-7.93). Preoperative low skeletal muscle mass was only associated with infectious complications (OR 2.32; 95%CI 1.09-4.92). In a multivariable model, low skeletal muscle density was of added predictive value for postoperative complications (OR 2.57; 95%CI 1.21-5.45) to the strongest existing predictor functional impairment (KATZ-ADL ≥ 2). CONCLUSION: Low skeletal muscle density, as a proxy of muscle quality, is associated with poor postoperative outcomes in older patients with advanced stage ovarian cancer. These findings can contribute to postoperative risk assessment and clinical decision making.
引用
- van der Zanden V, van Soolingen NJ, Viddeleer AR, et al. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer. Gynecol Oncol. 2021. PMID: 34112514. doi:10.1016/j.ygyno.2021.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。